Synchron, Inc. is a MedTech company focused on developing and commercializing minimally invasive brain-computer interface (BCI) technology. Their primary product, the Synchron Switch, is a permanently implanted device designed to help people with severe paralysis regain their independence by enabling them to control digital devices using their thoughts. This technology utilizes a stent-based approach, delivering the device directly to the brain via the jugular vein, eliminating the need for open-brain surgery, which significantly reduces the invasiveness and risk associated with traditional BCI implantation.

The company's mission is to empower people with paralysis to regain their independence and improve their quality of life through revolutionary BCI technology. Their innovative approach to implantation sets them apart from competitors who often rely on more invasive surgical methods. Synchron's focus is on developing a practical and accessible BCI system, prioritizing patient safety and ease of use. This is reflected in their commitment to streamlining the implantation procedure and minimizing recovery time.